EMFAT
KRTX
Emerald Mutual Fund Advisers Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,445
| Closed | -$2.78M | – | 256 |
|
|
2023
Q3 | $2.78M | Sell |
16,445
-6,278
| -28% | -$1.06M | 0.17% | 113 |
|
|
2023
Q2 | $4.93M | Sell |
22,723
-40,277
| -64% | -$8.73M | 0.27% | 104 |
|
|
2023
Q1 | $11.4M | Sell |
63,000
-16,466
| -21% | -$2.99M | 0.68% | 68 |
|
|
2022
Q4 | $15.6M | Sell |
79,466
-17,240
| -18% | -$3.39M | 0.97% | 43 |
|
|
2022
Q3 | $21.8M | Sell |
96,706
-5,265
| -5% | -$1.18M | 1.37% | 13 |
|
|
2022
Q2 | $12.9M | Sell |
101,971
-108,113
| -51% | -$13.7M | 0.75% | 54 |
|
|
2022
Q1 | $26.6M | Sell |
210,084
-19,371
| -8% | -$2.46M | 1.18% | 28 |
|
|
2021
Q4 | $30.1M | Buy |
229,455
+117,851
| +106% | +$15.4M | 1.06% | 38 |
|
|
2021
Q3 | $13.7M | Sell |
111,604
-87,492
| -44% | -$10.7M | 0.47% | 76 |
|
|
2021
Q2 | $22.7M | Buy |
199,096
+17,120
| +9% | +$1.95M | 0.74% | 50 |
|
|
2021
Q1 | $21.9M | Buy |
+181,976
| New | +$21.9M | 0.73% | 55 |
|